Stem Cell Therapeutics Overview

  • Year Founded
  • 2004

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 2

  • Investments
  • 1

Stem Cell Therapeutics General Information

Description

Developer of drug based therapies designed for the treatment of central nervous system diseases. The company's drug based therapies utilize drugs to stimulate a patient's own resident stem cells to repair neurological function lost due to diseases such as stroke, traumatic brain injury, multiple sclerosis and other neurodegenerative conditions, enabling the patients to get cured from nervous system disorders.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Bow Valley Square III
  • Suite 500 - 255 5th Avenue South West
  • Calgary, Alberta T2P 3G6
  • Canada
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Corporate Office
  • Bow Valley Square III
  • Suite 500 - 255 5th Avenue South West
  • Calgary, Alberta T2P 3G6
  • Canada

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Stem Cell Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Stem Cell Therapeutics‘s full profile, request access.

Request a free trial

Stem Cell Therapeutics Patents

Stem Cell Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20090081205-A1 Continuous dosing regimens for neural stem cell proliferating agents and neural stem cell differentiating agents Active 17-Mar-2006
US-20070111932-A1 Method of enhancing and/or inducing neuronal migration using erythropoietin Inactive 31-Jul-2003
US-20040092448-A1 Adding to multipotent neural stem cells; treating neurodegenerative disorders and brain injuries Active 31-Jul-2002
US-7368115-B2 Adding to multipotent neural stem cells; treating neurodegenerative disorders and brain injuries Inactive 31-Jul-2002
AU-2003250704-A1 Method of enhancing and/or inducing neuronal migration using erythropoietin Inactive 31-Jul-2002 A61K38/1808
To view Stem Cell Therapeutics’s complete patent history, request access »

Stem Cell Therapeutics Acquisitions (1)

Stem Cell Therapeutics’s most recent deal was a Reverse Merger with Trillium Therapeutics for . The deal was made on 12-Feb-2013.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Trillium Therapeutics 12-Feb-2013 Reverse Merger Drug Discovery
To view Stem Cell Therapeutics’s complete acquisitions history, request access »

Stem Cell Therapeutics Exits (1)

Stem Cell Therapeutics’s most recent exit was on 12-Feb-2013 from Trillium Therapeutics. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
Trillium Therapeutics 12-Feb-2013 Completed
To view Stem Cell Therapeutics’s complete exits history, request access »

Stem Cell Therapeutics FAQs

  • When was Stem Cell Therapeutics founded?

    Stem Cell Therapeutics was founded in 2004.

  • Where is Stem Cell Therapeutics headquartered?

    Stem Cell Therapeutics is headquartered in Calgary, Canada.

  • What industry is Stem Cell Therapeutics in?

    Stem Cell Therapeutics’s primary industry is Biotechnology.

  • Is Stem Cell Therapeutics a private or public company?

    Stem Cell Therapeutics is a Private company.

  • What is Stem Cell Therapeutics’s current revenue?

    The current revenue for Stem Cell Therapeutics is .

  • How much funding has Stem Cell Therapeutics raised over time?

    Stem Cell Therapeutics has raised $6.94M.

  • When was Stem Cell Therapeutics acquired?

    Stem Cell Therapeutics was acquired on 12-Feb-2013.

  • Who acquired Stem Cell Therapeutics?

    Stem Cell Therapeutics was acquired by Trillium Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process